We are on a mission to improve patient outcomes
We create novel medicines that benefit patients in need
About ResoTher Pharma
We target neutrophil driven inflamation and act as resolution therapy
ResoTher Pharma is a privately held biotechnology company located in Copenhagen, Denmark. The company is focused on discovering and developing peptide-based drugs as resolution therapy for diseases where inflammation plays a key pathological role.
Resother Pharma initiates First in Human studies with RTP-026
ResoTher Pharma today announced that the company has received approval [...]
ResoTher Pharma appoints Samra Sanni as VP of Research
ResoTher Pharma is pleased to announce the appointment of Samra [...]
ResoTher Pharma appoints Teis Vester as Chief Financial Officer
ResoTher Pharma is pleased to announce the appointment of Teis [...]
Latest News
Resother Pharma initiates First in Human studies with RTP-026
ResoTher Pharma today announced that the company has received approval [...]
ResoTher Pharma appoints Samra Sanni as VP of Research
ResoTher Pharma is pleased to announce the appointment of Samra [...]
ResoTher Pharma appoints Teis Vester as Chief Financial Officer
ResoTher Pharma is pleased to announce the appointment of Teis [...]
